Cancer Genetics Q4 Revenues Improve 73 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Cancer Genetics said after the close of the market on Wednesday that its fourth quarter revenues increased 73 percent year over year.

For the three months ended Dec. 31, 2013 the Rutherford, NJ-based cancer diagnostics firm reported revenues of $1.9 million, up from $1.1 million in the year-ago quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.